BioLineRx Annouces Positive Results for Phase 3 GENESIS Trial in Stem-Cell Mobilization

 BioLineRx Annouces Positive Results for Phase 3 GENESIS Trial in Stem-Cell Mobilization

BioLineRx Annouces Positive Results for Phase 3 GENESIS Trial in Stem-Cell Mobilization

Shots:
  •  Results of Ph 3 GENESIS trial comparing combination of BL-8040 plus G-CSF vs. G-CSF in multiple myeloma patients
  •  GENESIS is an open-label, single-arm study with 30 patients. First 11 patients showed safety and tolerability
  • Results: In trial 9/11 (82%) showed ≥6×106CD34 cells/kg after 2 apheresis; 7/11 (64%), showed ≥6×106 CD34 cells/kg post 1 session, which lead to reduction in treatment cost and better QoL
Click here to read full press release/ article | Ref: Biolinerx | Image: LinkedIn

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post